[HTML][HTML] Drug uptake-based chemoresistance in breast cancer treatment

H Muley, R Fado, R Rodriguez-Rodriguez… - Biochemical …, 2020 - Elsevier
Breast cancer is the most prevalent type of tumor and the second leading cause of death
due to cancer among women. Although screening methods, diagnosis and therapeutic …

SLC family transporters

X Liu - Drug transporters in drug disposition, effects and …, 2019 - Springer
Solute carrier (SLC) family transporters utilize an electrochemical potential difference or an
ion gradient generated by primary active transporters for transporting their substrates across …

Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management

MA Khan, KS Vikramdeo, SK Sudan, S Singh… - Seminars in cancer …, 2021 - Elsevier
Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer,
contributing to the high mortality-to-incidence ratio. Management of the platinum-resistant …

Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition

F Zhou, L Zhu, K Wang, M Murray - Advanced Drug Delivery Reviews, 2017 - Elsevier
Drug pharmacokinetics is influenced by the function of metabolising enzymes and
influx/efflux transporters. Genetic variability of these genes is known to impact on clinical …

Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation

R Farahzadi, MS Hejazi, O Molavi… - Oxidative Medicine …, 2023 - Wiley Online Library
Metabolic reprogramming is a common hallmark of cancer cells. Cancer cells exhibit
metabolic flexibility to maintain high proliferation and survival rates. In other words …

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin

E Andreev, N Brosseau, E Carmona… - Scientific reports, 2016 - nature.com
Anthracyclines such as daunorubicin are anticancer agents that are transported into cells
and exert cytotoxicity by blocking DNA metabolism. Although there is evidence for active …

Carnitine traffic in cells. Link with cancer

L Console, M Scalise, T Mazza, L Pochini… - Frontiers in Cell and …, 2020 - frontiersin.org
Metabolic flexibility is a peculiar hallmark of cancer cells. A growing number of observations
reveal that tumors can utilize a wide range of substrates to sustain cell survival and …

The relationship between actin cytoskeleton and membrane transporters in cisplatin resistance of cancer cells

T Shimizu, T Fujii, H Sakai - Frontiers in cell and developmental …, 2020 - frontiersin.org
Cisplatin [cis-diamminedichloroplatinum (II)] is a platinum-based anticancer drug widely
used for the treatment of various cancers. It forms interstrand and intrastrand cross-linking …

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer

K Myint, R Biswas, Y Li, N Jong, S Jamieson, J Liu… - Scientific Reports, 2019 - nature.com
Oxaliplatin is important for the clinical treatment of colorectal cancer and other
gastrointestinal malignancies, but tumour resistance is limiting. Several oxaliplatin …

Role of SLC transporters in toxicity induced by anticancer drugs

KM Huang, ME Uddin, D DiGiacomo… - Expert opinion on …, 2020 - Taylor & Francis
Introduction. Membrane transporters are integral to the maintenance of cellular integrity of all
tissue and cell types. While transporters play an established role in the systemic …